Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...
A new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the ...
FOX 5 spoke exclusively with a participant in a study for a new injectable drug to prevent HIV. Emory University medical ...
Nearly all of Latin America was excluded from the deal, sparking concern the world is missing a critical opportunity to stop ...
Health experts say lenacapavir could reduce the number of global HIV infections significantly. But it needs to be cheaper to ...
A new HIV prevention method, Lenacapavir, administered as a twice-yearly injection, has demonstrated superior results ...
While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...
Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...
Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons,” published in the November 2024 issue of Infectious ...
"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...
Global partners have supported Africa’s progress in HIV vaccine research and development. Organisations such as the US ...
A deal that allows manufacturers to produce generic versions of lenacapavir has left out some Eastern European countries ...